Item 9 Labs Corp. ( INLB) - Key Metrics
INLB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2023Q3 | $0.05 | -$0.06 | $0 | $0 |
| 2023Q2 | $0.06 | -$0.03 | $0 | $0 |
| 2023Q1 | $0.05 | -$0.03 | -$0.01 | -$0.01 |
| 2022Q4 | $0.04 | -$0.19 | $0 | -$0.02 |
| 2022Q3 | $0.05 | -$0.06 | -$0.02 | -$0.02 |
INLB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2023Q3 | 0% | -0.23 |
| 2023Q2 | 0% | -0.74 |
| 2023Q1 | 0% | -0.95 |
| 2022Q4 | 0% | -0.52 |
| 2022Q3 | 0% | -3.51 |
INLB Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2023Q3 | 1.60% | 0% |
| 2023Q2 | 3.01% | 0% |
| 2023Q1 | -10.82% | 0% |
| 2022Q4 | -4.32% | 0% |
| 2022Q3 | -2.70% | 0% |
INLB
Price: $0
52 week price:
Earnings Per Share: -0.33 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 10236